Wendy Martinez, MD
Obstetrics & Gynecology · Voorhees, NJNPI 1265504666
Payments from drug & device makers
Across 373 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$635
- Astellas Pharma US Inc$558
- Mayne Pharma Commercial LLC$465
- Amgen$426
- Pfizer$411
- Exeltis, USA Inc.$348
- plus $3K from 35 others
What the payments were for
- Food & beverage$5,49896%
- Education$2354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $635 |
| Astellas Pharma US Inc | 17 | $558 |
| Mayne Pharma Commercial LLC | 37 | $465 |
| Amgen | 31 | $426 |
| Pfizer | 29 | $411 |
| Exeltis, USA Inc. | 22 | $348 |
| Therapeuticsmd, Inc. | 16 | $312 |
| Evofem Biosciences, Inc. | 26 | $253 |
| Avion Pharmaceuticals | 22 | $224 |
| Exact Sciences | 10 | $198 |
| Bayer | 10 | $178 |
| Shield Therapeutics Inc | 4 | $172 |
| Novo Nordisk | 4 | $156 |
| Sumitomo Pharma America, Inc. | 8 | $138 |
| Mylan Pharmaceuticals Inc. | 8 | $134 |
| Merck | 9 | $131 |
| Myovant Sciences Inc. | 7 | $108 |
| Agile Therapeutics, Inc. | 6 | $103 |
| Hologic Sales And Service, LLC | 5 | $102 |
| Daiichi Sankyo Inc. | 7 | $96 |
| Millicent US Inc | 5 | $82 |
| Coopersurgical, Inc. | 3 | $55 |
| Organon | 3 | $47 |
| Cumberland Pharmaceuticals, Inc. | 2 | $43 |
| AMAG Pharmaceuticals, Inc. | 3 | $42 |
| Radius Health, Inc. | 3 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Sage Therapeutics, LLC | 2 | $33 |
| Astellas Pharma Global Development | 1 | $23 |
| Tempus AI, Inc | 1 | $22 |
| Abiomed | 1 | $22 |
| Axonics, Inc. | 1 | $20 |
| Vivus LLC | 1 | $17 |
| Lupin Inc. | 1 | $15 |
| Scynexis, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Aspira Women's Health Inc | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,733 in reported general payments places this provider in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 53 | $28,503 |
| MyrbetriqMirabegron | 13 | $14,517 |
| Estradiol | 96 | $8,330 |
| Risedronate Sodium DrRisedronate Sodium | 13 | $5,680 |
| Estradiol (Twice Weekly)Estradiol | 25 | $2,892 |
| Estradiol (Once Weekly)Estradiol | 19 | $2,453 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 22 | $2,436 |
| Risedronate Sodium | 22 | $2,230 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 86 | $2,047 |
| Raloxifene Hcl | 33 | $1,905 |
| ValacyclovirValacyclovir Hcl | 44 | $1,501 |
| Ibandronate Sodium | 28 | $971 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $862 |
| Betamethasone Dipropionate | 14 | $639 |
| ProgesteroneProgesterone, Micronized | 15 | $522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $411 | $28,50353 claims |
| Astellas Pharma US IncMyrbetriq | $558 | $14,51713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Other obstetrics & gynecology in Voorhees
- Geoffrey BowersVoorhees$228K
- Paula JasionowskiVoorhees$193K
- Jeffrey LevineVoorhees$15K
- Richard DittrichVoorhees$9K
- Donna D EliaVoorhees$9K
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.